Author:
Shimo Takeo,Ashizawa Naoki,Moto Mitsuyoshi,Iwanaga Takashi,Nagata Osamu
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference7 articles.
1. Ashizawa N, Shimo T, Matsumoto K, Oba K, Nakazawa T, Nagata O (2006) Strain differences in the responsiveness between Sprague-Dawley and Fischer rats to nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor. Toxicol Appl Pharmacol 217:260–265
2. Elion GB, Callahan S, Nathan H, Bieber S, Rundles RW, Hitchings GH (1963) Potentiation by inhibition of drug degradation. Biochem Pharmacol 12:85–93
3. European Medicines Agency (2008) CHMP assessment report for adenuric (febuxostat). Doc Ref: EMEA/258531
4. Hitchings GH (1966) Effects of allopurinol in relation to purine biosynthesis. Ann Rheum Dis 25:601–607
5. Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K (1999) A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats. Res Commun Mol Pathol Pharmacol 104:307–319
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献